Estd. 2008 Vol. 8 | No.1 |152-155| January - March | 2015 ISSN: 0974-1496 | e-ISSN: 0976-0083 | CODEN: RJCABP http://www.rasayanjournal.com http://www.rasayanjournal.co.in MICROBIAL ASSAY OF NOVEL 2-S-TETRA-O-BENZOYL-DGLUCOPYRANOSYL-1-ARYL-5-HEPTA-O-BENZOYL-β-DLACTOSYL-2-ISOTHIOBIURETS Kedar P. Pande Mauli College of Engineering and Technology, Shegaon-444203 (Maharashtra) INDIA. E-mail : kedarpande@yahoo.co.in ABSTRACT The present work aims to synthesize and screen the antifungal and antibacterial activities of a series of new 2-Stetra-O-benzoyl-D-glucopyranosyl-1-aryl-5-hepta-O-benzoyl-β-D-lactosyl-2-isothiobiurets by the interaction of hepta-O-benzoyl-β-D-lactosyl isocyanate and S-tetra-O-benzoyl-D-glucopyranosyl-1-aryl isothiocarbamides. The identities of these newly synthesised compounds have been established on the basis of usual chemical transformations and IR, 1HNMR and Mass spectral studies. These synthesized products were evaluated for their antimicrobial activity against some pathogenic organisms. Some of the products displayed promising activity. Keywords: Lactosylisocyanate, glucopyranosylisothiocarbamides, lactosylisothiobiurets, antimicrobial activity. ©2015 RASĀYAN. All rights reserved INTRODUCTION Carbohydrate biosynthetic pathway is often amenable to interception with synthetic unnatural subtracts1. Such metabolic interference can block the expression of oligosaccharides or alter the structures of sugars presented on cells. The applications of glycosidase inhibitors2-5 to agricultural and medical fields and the prospect for new therapeutic applications are reconsidered. These chemical approaches are contributing great insight into the countless biological functions of oligosaccharides6-8. Hence, it was the thought of interest to synthesize these N-lactosides9 and to study their antimicrobial activity against gram +ve and gram –ve micro-organisms with the help of cup plate agar diffusion method. In present communication, we report the microbial assay of newly synthesised 2-S-tetra-Obenzoyl-D-glucopyranosyl-1-aryl-5-hepta-O-benzoyl-β-D-lactosyl-2-isothiobiurets. EXPERIMENTAL All the chemicals and solvents were obtained from commercial and purified using standard procedure wherever required. Melting points were taken by the open capillary method and were uncorrected. The reactions were monitored by thin layer chromatography on silica gel G plates (Merck silica- 60 F258). Optical rotations [α]D31 were measured on the Equip-Tronics EQ-800 Digital Polarimeter at 31oC in CHCl3. The structures of all the newly synthesized compounds were confirmed by IR Spectra which recorded on Perkin-Elmer spectrum RXI FTIR Spectrometer (Range: 4000-450 cm-1). 1H NMRwas obtained on Bruker DRX-300 NMR spectrometer operating at 300 MHz Samples were prepared in CDCl3 with TMS as an internal reference. Mass spectra were obtained on Thermo Finnegan LCQ Advantage max ion trap mass spectrometer. General Procedure Synthesis of 2-S-tetra-O-benzoyl-D-glucopyranosyl-1-aryl-5-hepta-O-benzoyl-β-D-lactosyl-2isothiobiurets (3a-g) A 0.005M of S-tetra-O-benzoyl-D-glucopyranosyl-1-aryl isothiocarbamides(2a-g) in a 5ml of benzene was added to a 0.005M solution of hepta-O-benzoyl-β-D-lactosyl isocyanate(1) in 15ml benzene, the reaction mixture was reflux over boiling water bath for 5hr. After refluxing, the solvent was distilled off and the sticky residue obtained was triturated with petroleum ether (60-80 oC) to afford a solid (3a-g). The product was purified by chloroform petroleum ether. MICROBIAL ASSAY OF ISOTHIOBIURETS Kedar P. Pande Vol. 8 | No.1 |152-155 | January - March | 2015 RESULTS AND DISCUSSIONS Herein, we report the synthesis of various 2-S-tetra-O-benzoyl-D-glucopyranosyl-1-aryl-5hepta-O-benzoyl-β-D-lactosyl-2-isothiobiurets (3a-f) by inteaction of hepta-O-benzoyl-β-Dlactosyl isocyanate(1) and S-tetra-O-benzoyl-D-glucopyranosyl-1-aryl isothiocarbamides(2ag). All products were crystallized from ethanol before recording the physical data. The purity of compound was checked by TLC. The spectral analysis10-12 IR, 1HNMR and Mass spectra of the product were observed. Optical rotation of the product was also recorded. All the compounds have been screen for both antimicrobial and antifungal activity using cup plate agar diffusion method13-14 by measuring the inhibition zone in mm. Amikacin (100ug/mL) was used as a standard for antibacterial activity and Fluconazole (100ug/mL) was used as a standard for antifungal acitivity. OBz OBz O OBz BzO O O N=C=O O BzO BzO OBz RNH + OBz HN (1) Hepta-O-benzoyl-β β-D-lactosyl isocyanate OBz C S (2a-g) S-tetra-O-benzoyl-D-glucopyranosyl1-aryl isothoicarbamides Benzene Reflux, 5hr O OBz OBz OBz NH C O BzO OBz RNH O O BzO OBz OBz OBz N C BzO OBz OBz OBz S O (3a-g) 2-S-tetra-O-benzoyl-D-glucopyranosyl-1-aryl-5-hepta-O-benzyl-β β-D-lactosyl-2-isothiobiurets Where, Bz = COC6H5, R = (a) phenyl, (b) o-tolyl, (c) m-tolyl, (d) p-tolyl, (e) o-Cl-phenyl, (f) m-Cl-phenyl, (g) p-Cl-phenyl. Scheme-1 Spectral Data 3a: White solid, yield : 60%, mp : 130-132oC, [α]31D : -50.01o (c, 0.93, CHCl3), Rf = 0.42 (Pet. Ether : Acetone, 3:2); IR (KBr, cm-1): υ 3068 (Ar-H), 1729 (C=O), 3465 (N-H), 1653 (C=N), 1269 (C-N), 771 (C-S), 1101 & 1027 (Characteristic of Lactose); 1H NMR (CDCl3): δ 8.02-7.11 (42H, m, Ar-H), 5.21-5.15 (2H, s, NH protons), 6.28-3.89 (14H, m, lactosyl and glucosyl protons); Mass (m/z): 1825 (M+), 1053, 948, 932, 579, 531, 135. Anal.Calcd.for C103H83O27N3SCl, Requires: C, 67.72; H, 4.54; N, 2.30; S, 1.75; Found: C, 67.68; H, 4.50; N, 3.24; S, 1.71%. 3c: Yellow solid, yield : 53%, mp : 108-110oC, [α]31D : +82.9o (c, 0.93, CHCl3), Rf = 0.37 (Pet. Ether : Acetone, 3:2); IR (KBr, cm-1): υ 3066 (Ar-H), 1730 (C=O), 3451 (N-H), 1653 (C=N), 1270 (C-N), 709 (C-S), 1069 & 1025 (Characteristic of Lactose); 1H NMR (CDCl3): δ 8.20-7.12 (44H, m, Ar-H), 5.12-5.10 (2H, s, NH protons), 6.22-3.73 (14H, m, lactosyl and glucosyl protons); Mass (m/z): 1839 (M+), 1053, 948, 932, 579, 531, 135. Anal.Calcd.for C104H85O27N3S, Requires: C, 67.86; H, 4.62; N, 2.28; S, 1.74; Found: C, 67.79; H, 4.59; N, 2.22; S, 1.71%. 3f: Light yellow solid, yield : 55%, mp : 126-127oC, [α]31D : +69.28o (c, 0.93, CHCl3), Rf = 0.48 (Pet. Ether : Acetone, 3:2); IR (KBr, cm-1): υ 3067 (Ar-H), 1729 (C=O), 3448 (N-H), 1601 (C=N), 1270 (C-N), 772 (C-S), 1099 & 1025 (Characteristic of Lactose); 1H NMR (CDCl3): δ 8.28-7.19 (44H, m, MICROBIAL ASSAY OF ISOTHIOBIURETS 153 Kedar P. Pande Vol. 8 | No.1 |152-155 | January - March | 2015 Ar-H), 5.23-5.21 (2H, s, NH protons), 5.88-4.19 (14H, m, lactosyl and glucosyl protons); Mass (m/z): 1859 (M+), 1053, 948, 932, 579, 531, 135. Anal.Calcd.for C103H82O27N3SCl, Requires: C, 66.46; H, 4.40; N, 2.25; S, 1.72; Found: C, 66.40; H, 4.32; N, 2.19; S, 1.68%. Antimicrobial Studies All compounds were screened for antibacterial activity against Escherichia coli, Staphylococcus aureus, Proteus vulgaris, Salmonella typhi, Klebsiella pneumoniae, Pseudomonas aeruginosa, Bacillus subtilis in nutrient agar medium and for antifungal activity against Candida albicance and Aspergillus niger in potato dextrose agar medium. These sterilized agar media were poured into Petri dishes and allowed to solidify on the surface of the media, microbial suspensions were spread with the help of sterilized triangular loop. A stainless steel cylinder of 8 mm diameter (pre-sterilized) was used to bore the cavities. 0.1 ml portions of the test compounds in solvent were added into these wells. The drug solution was allowed to diffuse for about an hour into the medium. The plates were incubated at 37oC for 24 hr and 30oC for 48 hr for antibacterial and antifungal activities respectively. The zone of inhibition observed around the cups after respective incubation was measured. The results are presented in Table-1. Antibacterial studies of these compounds indicated that compounds 3a and 3d were found to be active against E.coliand rest of were found to be moderately active. Compound 3a, 3b and 3g exhibited most significant activity against S.aureusand compound 3a, 3b and 3d towards P. seudomonas. All other compounds exhibited low to moderate activity. The results of antifungal activities are also tabulated in Table1. Almost all compounds are most effectively active against C. albicance and A. niger. Table-1: Antimicrobial activities of newly synthesized 2-S-tetra-O-benzoyl glucopyranosyl-1-aryl-5-hepta-Obenzoyl-β-D-lactosyl-2-isothiobiurets (3a-g) Antibacterial** Compound Antifungal** E. S. P. S. Ps. K. B. C. A. coli Aureus vulgaris typhi aeruginosa Pneumoniae subtilis albicance niger 3a 20 22 17 16 21 19 11 20 22 3b 16 20 19 11 20 18 - 21 20 3c 15 18 - 10 12 13 20 19 21 3d 21 17 18 10 20 17 15 20 19 3e 15 - 13 - - 12 12 18 20 3f 16 19 17 12 16 16 10 20 22 3g 17 21 16 13 19 19 - 21 23 Amikacin 25 26 23 25 24 26 24 - - Fluconazole - - - - - 26 28 **zone of inhibition in mm (15 or less) resistance, (16-20 mm) moderate and (more than 20mm) sensitive. Escherichia coli (E. coli), Staphylococcus aureus (S. aureus), Proteus vulgaris (P. vulgaris), Salmonella typhi (S. typhi), KlebsiallaPneumoniae (K. Pneumoniae), Pseudomonas auriginosa (P. auriginosa), Bacillus subtilis (B. subtlis), Candida albicance (C. albicance) and Aspergillusniger (A. niger). CONCLUSION The new lactosyl isothiobiurets exhibits promising antibacterial and antifungal activities against the organism tested. The method adopted in this investigation is simple efficient inexpensive and is useful in synthesizing pharmacologically important molecules. MICROBIAL ASSAY OF ISOTHIOBIURETS 154 Kedar P. Pande Vol. 8 | No.1 |152-155 | January - March | 2015 ACKNOWLEDGEMENT Author is thankful to SAIF, CDRI, Lucknow for providing spectral data and Dr. C. M. Jadhao, Mauli College of Engineering and Technology, Shegaon for providing necessary facilities. REFERENCES 1. 2. 3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 13. 14. N. Asano, Glycobiology, 13(10), 93(2003). A. D. Elbein, Annu. Rev. Biochem., 56, 497(1987). A. D. Elbein, FASEB Journal, 5(15), 3055(1991). A. Mehta, N. Zitzmann, P. M. Rudd, T. M. Block and R.A. Dwek, FEBS Letters, 430 (12), 17 (1998). V. N. Ingle, U. G. Upadhyay and S.T. Kharche, Indian J. Chem., 44B, 1859(2005). T.W.Rademacher, R. B. Parekh and A.R. Dwek, Annu. Rev. BioChem., 5, 785(1998). P. Gagneau and A. Varki, Glycobiology, 9, 747(1999). R.C.N.Reic, S.C. Oda, M.V. De Almeida, M.C.S. Lourenco, F.R.C. Vicente, N.R.Barbosa, R. Trevizani, P.L. C. Santos and M. Le Hyaric, J. Braz. Chem. Soc., 19(6)223(2008). K. P. Pande and S. P. Deshmukh, DerPharmaChemica, 3(6), 28(2011). R. M.Silverstein and F. X. Webster, “Spectrometric Identification of Organic Compounds”, 6th ed., John Wiley and Sons, Inc, New York., 119(2011). D. H. Williams and I. Fleming, “Spectroscopic Methods in Organic Chemistry”, 5th ed., Tata McGraw-Hill, 53(2004). J. R. Dyer, “Applications of Absorption Spectroscopy of Organic Compounds”, PHI Learning Private Limited, New Delhi, 88(2010). F.Kawangh, Analytical Microbiology, Academic press, New York, 47(1963). British pharmacopoeia-II, Biological assay and Tests, The Stationary Office Ltd., London; A-205, 102(1998). [RJC-1220/2015] MICROBIAL ASSAY OF ISOTHIOBIURETS 155 Kedar P. Pande
© Copyright 2024